Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study

被引:47
|
作者
Schneider, Karolin [1 ]
Marbaix, Etienne [2 ,3 ]
Bouzin, Caroline [4 ]
Hamoir, Marc [5 ]
Mahy, Pierre [6 ]
Bol, Vanesa [1 ]
Gregoire, Vincent [1 ,7 ]
机构
[1] Catholic Univ Louvain, Ctr Mol Imaging Radiotherapy & Oncol MIRO, Inst Expt & Clin Res IREC, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Pathol, Brussels, Belgium
[3] Catholic Univ Louvain, de Duve Inst, Cell Biol Unit, Brussels, Belgium
[4] Catholic Univ Louvain, Inst Expt & Clin Res IREC, IREC Imaging Platform, Brussels, Belgium
[5] St Luc Univ Hosp, King Albert II Canc Inst, Dept Otorhinolaryngol & Head & Neck Surg, Brussels, Belgium
[6] St Luc Univ Hosp, King Albert II Canc Inst, Dept Stomatol & Maxillofacial Surg, Brussels, Belgium
[7] St Luc Univ Hosp, King Albert II Canc Inst, Dept Radiat Oncol, Brussels, Belgium
关键词
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; LYMPHOCYTES; PREVALENCE; PROGNOSIS; SURVIVAL; MARKERS; TUMORS;
D O I
10.1080/0284186X.2018.1445287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) prevalence in oropharynx squamous cell carcinoma (OPSCC) is on the rise. HPV-linked OPSCCs represent a distinct clinical entity with a better treatment response and patient survival compared to tumors not linked to HPV. An emerging role in treatment response has been attributed to immune cell infiltration in human tumors. In this study, we investigated immune cell infiltration in human SCC of the head and neck region and its relation to overall survival after treatment with surgery (with or without radiotherapy) or concomitant chemo (or cetuximab)-radiotherapy. Materials and methods: Paraffin-embedded tumor samples of 136 patients with SCC of the larynx, hypopharynx, oral cavity and oropharynx were processed for immunohistochemical detection of CD3(+) T-cells, CD8(+) cytotoxic T-cells, CD20(+) B-cells and CD163(+) M2 macrophages within the tumor infiltrated area. Clinico-pathological data were analyzed as a function of tumor location and p16-status. Immune cell infiltration was represented as stained area on the whole tumor infiltrated area, compared for the different tumor locations and correlated to patient survival. Results: Patients with oropharynx tumors expressing significant p16 levels (p16-sg) had a 5-year overall survival of 85% compared to 43% for patients with no significant p16 (p16-ns) expression (HR: 0.3 - 95% CI: 0.1-0.6). Median immune cell infiltration (T- and B-lymphocytes) was significantly elevated in p16-sg oropharyngeal tumors, compared to p16-ns oropharyngeal tumors and to all other head and neck tumor locations. No difference in CD163(+) macrophage infiltration was observed across the different patient groups. In the whole population, a high infiltration by CD3(+) T-lymphocytes was associated to a significantly (p=.03; HR: 0.6, 95% CI: 0.4-0.97) better overall survival. Conclusion: Oropharynx cancer with significant p16 expression showed an increased overall survival and elevated T- and B-lymphocyte infiltration, which suggests a prognostic relevance of immune cell infiltration.
引用
收藏
页码:1165 / 1172
页数:8
相关论文
共 50 条
  • [31] The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration
    Chen, Qingjuan
    Chen, Jiankang
    Lu, Zuzhuang
    Nian, Rui
    Li, Wanjun
    Yao, Zhongqiang
    Mou, Shangdong
    Liu, Ying
    Cao, Xia
    He, Wenjing
    Zhu, Chenjing
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [32] LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma
    Kai Sun
    Ri-xin Chen
    Jing-zhang Li
    Zhan-xiong Luo
    Hereditas, 159
  • [33] Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma
    Blise, Katie E.
    Sivagnanam, Shamilene
    Banik, Grace L.
    Coussens, Lisa M.
    Goecks, Jeremy
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [34] The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
    Niels E. Wondergem
    Irene H. Nauta
    Tara Muijlwijk
    C. René Leemans
    Rieneke van de Ven
    Current Oncology Reports, 2020, 22
  • [35] Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma
    Carlos N. Prieto-Granada
    Bin Xu
    Bayan Alzumaili
    Mohamed Rizwan Haroon Al Rasheed
    Antoine Eskander
    Danny Enepekides
    Snehal G. Patel
    Todd M. Stevens
    Snjezana Dogan
    Ronald Ghossein
    Nora Katabi
    Virchows Archiv, 2021, 479 : 729 - 739
  • [36] CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
    Wei, Zhengyu
    Shen, Yiming
    Zhou, Chongchang
    Cao, Yujie
    Deng, Hongxia
    Shen, Zhisen
    BIOENGINEERED, 2022, 13 (05) : 13784 - 13800
  • [37] μ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
    Jank, Bernhard J.
    Haas, Markus
    Schnoell, Julia
    Schlederer, Michaela
    Heiduschka, Gregor
    Kenner, Lukas
    Kadletz-Wanke, Lorenz
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [38] Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma
    Prieto-Granada, Carlos N.
    Xu, Bin
    Alzumaili, Bayan
    Al Rasheed, Mohamed Rizwan Haroon
    Eskander, Antoine
    Enepekides, Danny
    Patel, Snehal G.
    Stevens, Todd M.
    Dogan, Snjezana
    Ghossein, Ronald
    Katabi, Nora
    VIRCHOWS ARCHIV, 2021, 479 (04) : 729 - 739
  • [39] AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma
    Mao, Linwei
    Pan, Zhiyong
    Chen, Wenzhi
    Hu, Weiqun
    Chen, Xiufen
    Dai, Huiting
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [40] Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with favorable prognosis
    Tan, Haosheng
    Yang, Huaiyu
    Qian, Jiaxin
    Liu, Shaoyan
    Yan, Dangui
    Wei, Liyuan
    Liu, Wensheng
    MEDICINE, 2023, 102 (32) : E34761